Do You Have Any Of These Rare Disease Biotech Stocks In Your Portfolio?

Rare commodities are worth more than good is a Chinese adage. And more so when it is in the sought-after drug space. Rare and ultra-rare diseases, also called orphan and ultra-orphan diseases, as the names imply, affect very small numbers of patients. So why the clamor?

from RTT - Biotech http://ift.tt/1ZmbCKw
via IFTTT